Boothbay Fund Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Boothbay Fund Management’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,062	Closed	-$127K	–	2430
2021 Q2	$127K	Buy	+2,062	New	+$187K	﹤0.01%	1692
2021 Q1	–	Sell	-928	Closed	-$132K	–	2014
2020 Q4	$132K	Buy	+928	New	+$99K	﹤0.01%	1151
2019 Q2	–	Sell	-142	Closed	-$17K	–	995
2019 Q1	$17K	Sell	142 -107	-43%	-$14.6K	﹤0.01%	727
2018 Q4	$35K	Buy	+249	New	+$62.6K	0.01%	602

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boothbay Fund Management's ONCS Position: Q3 2021 in Review

Boothbay Fund Management sold out of OncoSec Medical Incorporated (ONCS) in Q3 2021, closing a stake of 2,062 shares — an estimated $127K sold.

Boothbay Fund Management first reported a position in ONCS in Q4 2018 and held it in 4 quarters. The position peaked at $132K in Q4 2020. 31 funds tracked by Wall St. Rank hold ONCS as of Q3 2021.

Boothbay Fund Management reported no remaining OncoSec Medical Incorporated position as of Q3 2021 after selling out during the quarter.
Boothbay Fund Management sold 2,062 OncoSec Medical Incorporated shares in Q3 2021, an estimated $127K.
Boothbay Fund Management first reported a position in OncoSec Medical Incorporated in Q4 2018 and held it in 4 quarters.
Boothbay Fund Management's OncoSec Medical Incorporated position peaked at $132K in Q4 2020.
31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.